CORRECT: Vectura Licenses Patents To GlaxoSmithKline – Wall Street Journal


Stockopedia

CORRECT: Vectura Licenses Patents To GlaxoSmithKline
Wall Street Journal
VX) generics unit Sandoz handed back the US rights to VR315, a generic version of an asthma drug, to Vectura. Analysts said it signaled Sandoz wasn't sure
INTERVIEW: Vectura Patents For GSK's 573719 And 642444Wall Street Journal
Vectura and GlaxoSmithKline sign agreement over asthma patentsStockopedia
Vectura boosted by deal with GSK worth over $30 million upfront plus royalties The Pharma Letter (subscription)

all 23 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *